Literature DB >> 32719463

Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria.

Eikan Mishima1, Yukino Funayama2, Takehiro Suzuki3, Fumiko Mishima4, Fumihiko Nitta4, Takafumi Toyohara3, Koichi Kikuchi3, Hiroshi Kunikata4, Junichiro Hashimoto5, Mariko Miyazaki3, Hideo Harigae3,6, Toru Nakazawa4, Sadayoshi Ito3,7, Takaaki Abe8,9,10.   

Abstract

Malignant hypertension, a form of hypertensive emergency, causes acute damage in vital organs such as the brain, eyes, and kidneys. We aimed to examine the concurrency of acute hypertensive damage across the target organs to elucidate the underlying analogous pathophysiology. This single-center retrospective study evaluated the characteristics of organ damage, short-term clinical course, and interorgan relationships in patients with malignant hypertension treated between 2008 and 2019. Baseline characteristics of 20 patients who met our inclusion criteria were mean age 48 ± 13 years and blood pressure 222 ± 18/142 ± 16 mmHg; the median estimated glomerular filtration rate and urinary protein level were 49 mL/min/1.73 m2 (interquartile range [IQR] 27-79) and 1.9 g/g creatinine (IQR 0.2-4.0), respectively. Posterior reversible encephalopathy syndrome (PRES) was found in 60% of patients with major involvement and a wide variety of distribution patterns in the brainstem. In the fundus, serous retinal detachment was found in 60% of patients. Patients with PRES and serous retinal detachment showed higher levels of urinary protein than those without symptoms (P = 0.007 and 0.02, respectively), and proteinuria >1 g/g creatinine highly complicated both PRES and serous retinal detachment (91%). Matrix analysis also showed that the three symptoms were highly associated with each other. These results demonstrate the close relationship and concurrency of hypertensive acute organ damage in the brain, eyes, and kidneys. A common analogous mechanism, such as hyperperfusion-induced capillary leakage in each organ, implies an underlying pathophysiology of PRES, serous retinal detachment, and proteinuria.

Entities:  

Keywords:  Hypertensive emergency; Hypertensive retinopathy; Posterior reversible encephalopathy syndrome (PRES); Serous retinal detachment; Thrombotic microangiopathy

Mesh:

Substances:

Year:  2020        PMID: 32719463     DOI: 10.1038/s41440-020-0521-2

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  39 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).

Authors:  Satoshi Umemura; Hisatomi Arima; Shuji Arima; Kei Asayama; Yasuaki Dohi; Yoshitaka Hirooka; Takeshi Horio; Satoshi Hoshide; Shunya Ikeda; Toshihiko Ishimitsu; Masaaki Ito; Sadayoshi Ito; Yoshio Iwashima; Hisashi Kai; Kei Kamide; Yoshihiko Kanno; Naoki Kashihara; Yuhei Kawano; Toru Kikuchi; Kazuo Kitamura; Takanari Kitazono; Katsuhiko Kohara; Masataka Kudo; Hiroo Kumagai; Kiyoshi Matsumura; Hideo Matsuura; Katsuyuki Miura; Masashi Mukoyama; Satoko Nakamura; Takayoshi Ohkubo; Yusuke Ohya; Takafumi Okura; Hiromi Rakugi; Shigeyuki Saitoh; Hirotaka Shibata; Tatsuo Shimosawa; Hiromichi Suzuki; Shori Takahashi; Kouichi Tamura; Hirofumi Tomiyama; Takuya Tsuchihashi; Shinichiro Ueda; Yoshinari Uehara; Hidenori Urata; Nobuhito Hirawa
Journal:  Hypertens Res       Date:  2019-09       Impact factor: 3.872

Review 3.  Acute Severe Hypertension.

Authors:  Aldo J Peixoto
Journal:  N Engl J Med       Date:  2019-11-07       Impact factor: 91.245

4.  Comparison of Renal Outcome among Japanese Patients with or without Microangiopathic Hemolysis in Malignant Phase Hypertension: A Single-Center Retrospective Study.

Authors:  Yoshikuni Nagayama; Yoshihiko Inoue; Kiyoko Inui; Ashio Yoshimura
Journal:  Nephron       Date:  2017-08-18       Impact factor: 2.847

Review 5.  Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein
Journal:  Lancet Neurol       Date:  2015-07-13       Impact factor: 44.182

Review 6.  Malignant hypertension and hypertensive emergencies.

Authors:  C Kitiyakara; N J Guzman
Journal:  J Am Soc Nephrol       Date:  1998-01       Impact factor: 10.121

7.  Hypertensive encephalopathy and the neurologic manifestations of malignant hypertension.

Authors:  E B Healton; J C Brust; D A Feinfeld; G E Thomson
Journal:  Neurology       Date:  1982-02       Impact factor: 9.910

8.  Fundus lesions in malignant hypertension. VI. Hypertensive choroidopathy.

Authors:  S S Hayreh; G E Servais; P S Virdi
Journal:  Ophthalmology       Date:  1986-11       Impact factor: 12.079

9.  Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort.

Authors:  Sébastien Rubin; Antoine Cremer; Romain Boulestreau; Claire Rigothier; Sophie Kuntz; Philippe Gosse
Journal:  J Hypertens       Date:  2019-02       Impact factor: 4.844

Review 10.  From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency.

Authors:  A Cremer; F Amraoui; G Y H Lip; E Morales; S Rubin; J Segura; B J Van den Born; P Gosse
Journal:  J Hum Hypertens       Date:  2015-11-19       Impact factor: 3.012

View more
  3 in total

Review 1.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

Review 2.  Cardiac Complications of Hypertensive Emergency: Classification, Diagnosis and Management Challenges.

Authors:  Mohammed A Talle; Ellen Ngarande; Anton F Doubell; Philip G Herbst
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-17

3.  What is the impact of blood pressure on neurological symptoms and the risk of ESKD in primary and secondary thrombotic microangiopathies based on clinical presentation: a retrospective study.

Authors:  Jean-Michel Halimi; Benjamin Thoreau; Florent von Tokarski; Adeline Bauvois; Juliette Gueguen; Nicolas Goin; Christelle Barbet; Sylvie Cloarec; Elodie Mérieau; Sébastien Lachot; Denis Garot; Adrien Lemaignen; Emmanuel Gyan; Franck Perrotin; Claire Pouplard; François Maillot; Philippe Gatault; Bénédicte Sautenet; Emmanuel Rusch; Véronique Frémeaux-Bacchi; Cécile Vigneau; Guillaume Bayer; Fadi Fakhouri
Journal:  BMC Nephrol       Date:  2022-01-20       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.